Matthew Cortese, MD, MPH, a hematologic oncologist at Roswell Park Comprehensive Cancer Center, shares that certain types of hard-to-treat lymphomas may be more receptive to immunotherapies than previously thought.
Dr. Cortese and his team also continue to work on trials to boost treatment efficacy while minimizing toxicity by considering different treatment sequences to create more durable remissions. Read more about our studies and patient stories here - https://physicianresources.roswellpark.org/videos/cellular-therapies-leading-to-new-treatment-options-for-lymphoma-patients
Learn more about Dr. Cortese here - https://www.roswellpark.org/matthew-cortese
Dr. Cortese and his team also continue to work on trials to boost treatment efficacy while minimizing toxicity by considering different treatment sequences to create more durable remissions. Read more about our studies and patient stories here - https://physicianresources.roswellpark.org/videos/cellular-therapies-leading-to-new-treatment-options-for-lymphoma-patients
Learn more about Dr. Cortese here - https://www.roswellpark.org/matthew-cortese
- Category
- Oncology

Be the first to comment